Skip to content

Metastatic Tumor Research and Outcomes Network

Metastatic Spine Tumor

The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Patient 18 or older.
* Patient diagnosed with a metastatic tumor of the spine
* Informed consent obtained, i.e.:

* Ability to understand the content of the patient information/ICF
* Willingness and ability to participate in the registry according to the Registry Plan
* Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site)

Exclusion Criteria:

• Patient diagnosed with a primary tumor of the spine.

Lieu de l'étude

Vancouver General Hospital and the University of British Columbia
Vancouver General Hospital and the University of British Columbia
Vancouver, British Columbia
Canada

Contactez l'équipe d'étude

Primary Contact

Charles G. Fisher, MD

[email protected]
McGill University Health Centre
McGill University Health Centre
Montréal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Michael Weber, MD

[email protected]
University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter
University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Arjun Saghal, MD

[email protected]
Winnipeg Spine Program University of Manitoba Department of Surgery
Winnipeg Spine Program University of Manitoba Department of Surgery
Winnipeg, Manitoba
Canada

Contactez l'équipe d'étude

Primary Contact

Michael Johnson, MD

[email protected]
Toronto Western Hospital Department of Neurosurgery Division of Surgery
Toronto Western Hospital Department of Neurosurgery Division of Surgery
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Michael G Fehlings, MD

[email protected]
(416) 603-5627
Étude parrainée par
AO Innovation Translation Center
Participants recherchés
Plus d'informations
ID de l'étude: NCT02830451